Рет қаралды 1,803
Dusty Majumdar, CEO of PredX Bio, shares how the company is revolutionizing personalized medicine and cancer care through genetic testing and explainable AI. PredX Bio’s cutting-edge platform uses spatial biology to uncover cancer’s underlying networks, empowering proactive health management and advancing healthcare and biopharma solutions. Discover how they're shaping the future of cancer treatment.